Industry Symposium by Bayer

IND 30 - Future horizons in liver health: how to optimize your patient pathway today

New trends in liver disease with a deep dive into different imaging modalities and their sutiability for liver patients, followed by practical tips and examples for optimal use of liver-specific contrast media.

IND 30-1

5 min

Introduction

Ahmed Ba-Ssalamah, Vienna / Austria

Introduction to topic and speakers

IND 30-2

10 min

What is the future of liver disease?

Thomas Berg, LEIPZIG / Germany

- Update the audience on the latest trends in liver disease, highlighting the impact these will have in their clinics and the emerging urgency for early diagnosis with a specific focus on metabolic liver disease

IND 30-3

20 min

Optimal precision diagnosis: right patient, right modality, right time

Valérie Vilgrain, Clichy / France
Peter R Galle, Mainz / Germany

- Share expert knowledge on the benefits and challenges of different imaging modalities including ultrasound, CT and MR. Discuss the subsequent effects each modality has on the patient pathway and final diagnosis by presenting a complex case study

IND 30-5

10 min

Gadoxetic acid-enhanced MRI: : how to practically improve focal liver lesions diagnosis

Luigi Grazioli, Brescia / Italy

- Discuss the properties of Gadoxetic acid and the appropriate clinical use as a liver specific contrast agent for MRI

IND 30-6

10 min

Gadoxetic acid-enhanced MRI: : how to practically improve focal liver lesions diagnosis

Irene Kain, Wien / Austria

- Present practical tips and examples of how to optimize your MR imaging workflow, including optimized workflows, how to prepare your patient, minimizing artifacts and obtaining a clear arterial phase with Gadoxetic acid

IND 30-7

5 min

Q&A

Ahmed Ba-Ssalamah, Vienna / Austria

Answering questions from the audience